Cargando…
The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis
OBJECTIVE: The debate pertaining to the association between Keratoconus (KC) and Mitral Valve Prolapse (MVP) continues to occur among physicians. The results of cross-sectional studies attempting to present the co-existing prevalence of these two diseases remain indeterminate. We compiled the first...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460702/ https://www.ncbi.nlm.nih.gov/pubmed/31782369 http://dx.doi.org/10.2174/1573403X15666191129100928 |
_version_ | 1783576663110451200 |
---|---|
author | Siordia, Juan A. Franco, Jimena C. |
author_facet | Siordia, Juan A. Franco, Jimena C. |
author_sort | Siordia, Juan A. |
collection | PubMed |
description | OBJECTIVE: The debate pertaining to the association between Keratoconus (KC) and Mitral Valve Prolapse (MVP) continues to occur among physicians. The results of cross-sectional studies attempting to present the co-existing prevalence of these two diseases remain indeterminate. We compiled the first meta-analysis to determine the pattern of prevalence between the two diseases. METHODS: Two separate literature searches for cross-sectional studies were performed for this meta-analysis. The first search encompassed finding literature comparing the prevalence of KC between patients with MVP and a control group. The second search pertained to finding studies comparing the prevalence of MVP patients with KC and a control group. RESULTS: Six studies reported the prevalence of MVP in patients with KC and a control group. The prevalence was 41.6% in patients with KC and 11.5% in patients without KC (OR = 7.06 [95% CI = 2.41-20.64]). There was a significant heterogeneity among the studies (I(2) = 84%). Two studies showed the prevalence of KC in patients with MVP and a control group. The prevalence was 17.0% in patients with KC and 2.9% in the control group (OR = 5.07 [95% CI = 1.08-23.83]). There was no heterogeneity within the analysis (I(2) = 0%). CONCLUSION: There is a statistically significant co-existing prevalence between MVP and KC. Patients with KC are more likely to present with MVP, and patients with MVP are more likely to present with KC. |
format | Online Article Text |
id | pubmed-7460702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-74607022021-05-01 The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis Siordia, Juan A. Franco, Jimena C. Curr Cardiol Rev Article OBJECTIVE: The debate pertaining to the association between Keratoconus (KC) and Mitral Valve Prolapse (MVP) continues to occur among physicians. The results of cross-sectional studies attempting to present the co-existing prevalence of these two diseases remain indeterminate. We compiled the first meta-analysis to determine the pattern of prevalence between the two diseases. METHODS: Two separate literature searches for cross-sectional studies were performed for this meta-analysis. The first search encompassed finding literature comparing the prevalence of KC between patients with MVP and a control group. The second search pertained to finding studies comparing the prevalence of MVP patients with KC and a control group. RESULTS: Six studies reported the prevalence of MVP in patients with KC and a control group. The prevalence was 41.6% in patients with KC and 11.5% in patients without KC (OR = 7.06 [95% CI = 2.41-20.64]). There was a significant heterogeneity among the studies (I(2) = 84%). Two studies showed the prevalence of KC in patients with MVP and a control group. The prevalence was 17.0% in patients with KC and 2.9% in the control group (OR = 5.07 [95% CI = 1.08-23.83]). There was no heterogeneity within the analysis (I(2) = 0%). CONCLUSION: There is a statistically significant co-existing prevalence between MVP and KC. Patients with KC are more likely to present with MVP, and patients with MVP are more likely to present with KC. Bentham Science Publishers 2020-05 2020-05 /pmc/articles/PMC7460702/ /pubmed/31782369 http://dx.doi.org/10.2174/1573403X15666191129100928 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Siordia, Juan A. Franco, Jimena C. The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis |
title | The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis |
title_full | The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis |
title_fullStr | The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis |
title_full_unstemmed | The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis |
title_short | The Association Between Keratoconus and Mitral Valve Prolapse: A Meta-Analysis |
title_sort | association between keratoconus and mitral valve prolapse: a meta-analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460702/ https://www.ncbi.nlm.nih.gov/pubmed/31782369 http://dx.doi.org/10.2174/1573403X15666191129100928 |
work_keys_str_mv | AT siordiajuana theassociationbetweenkeratoconusandmitralvalveprolapseametaanalysis AT francojimenac theassociationbetweenkeratoconusandmitralvalveprolapseametaanalysis AT siordiajuana associationbetweenkeratoconusandmitralvalveprolapseametaanalysis AT francojimenac associationbetweenkeratoconusandmitralvalveprolapseametaanalysis |